Abdominal Imaging

, Volume 36, Issue 2, pp 165–169

Incidental focal hypermetabolic colorectal lesions identified by positron emission tomography: prevalence of malignancy

Article

Abstract

Colorectal cancer is commonly diagnosed in the United State and is one of the leading causes of cancer deaths. Positron emission tomography has been used for the evaluation and management for patients with colorectal cancer. Frequently, abnormal incidental lesions are detected on positron emission tomography. This article will review current literature for the prevalence of malignancy and pre-malignancy in incidental focal hypermetabolic colorectal lesions detected by positron emission tomography and briefly discuss its clinical impact.

Key words

Positron emission tomography Incidental findings Colorectal Carcinoma Colonic adenoma Fluorodeoxyglucose 

References

  1. 1.
    Edwards BK, Ward E, Kohler BA, et al. (2010) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116:544–573PubMedCrossRefGoogle Scholar
  2. 2.
    Horner MJ, Ries LAG, Krapcho M, et al. (eds) SEER Cancer statistics review, 1975–2006, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2006/ (based on November 2008 SEER data submission, posted to the SEER web site, 2009)
  3. 3.
    O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96(19):1420–1425PubMedCrossRefGoogle Scholar
  4. 4.
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28(2):264–271PubMedCrossRefGoogle Scholar
  5. 5.
    van Kouwen MC, Nagengast FM, Jansen JB, Oyen WJ, Drenth JP (2005) 2-(18F)-Fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. J Clin Oncol 23(16):3713–3717PubMedCrossRefGoogle Scholar
  6. 6.
    de Geus-Oei LF, Vriens D, van Laarhoven HW, van der Graaf WT, Oyen WJ (2009) Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review. J Nucl Med 50(Suppl 1):43S–54SPubMedCrossRefGoogle Scholar
  7. 7.
    Meta J, Seltzer M, Schiepers C, et al. (2001) Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician’s perspective. J Nucl Med 42:586–590PubMedGoogle Scholar
  8. 8.
    Scott AM, Gunawardana DH, Kelley B, et al. (2008) PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med 49(9):1451–1457PubMedCrossRefGoogle Scholar
  9. 9.
    Gillies RJ, Robey I, Gatenby RA (2008) Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49(Suppl 2):24S–42SPubMedCrossRefGoogle Scholar
  10. 10.
    Plathow C, Weber WA (2008) Tumor cell metabolism imaging. J Nucl Med 49(Suppl 2):43S–63SPubMedCrossRefGoogle Scholar
  11. 11.
    Gu J, Yamamoto H, Fukunaga H, et al. (2006) Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-d-glucose uptake by positron emission tomography in colorectal cancer. Dig Dis Sci 51(12):2198–2205PubMedCrossRefGoogle Scholar
  12. 12.
    Jadvar H, Alavi A, Gambhir SS (2009) 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 50(11):1820–1827PubMedCrossRefGoogle Scholar
  13. 13.
    Riedl CC, Akhurst T, Larson S, et al. (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48(5):771–775PubMedCrossRefGoogle Scholar
  14. 14.
    Wang S, Mintz A, Mochizuki K, et al. (2007) Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts. Cancer Biol Ther 6(10):1649–1653PubMedCrossRefGoogle Scholar
  15. 15.
    Strauss LG, Koczan D, Klippel S, et al. (2008) Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors. J Nucl Med 49(8):1238–1244PubMedCrossRefGoogle Scholar
  16. 16.
    Cook GJR, Fogelman I, Maisey MN (1996) Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 26:308–314PubMedCrossRefGoogle Scholar
  17. 17.
    Kostakoglu L, Hardoff R, Mirtcheva R, et al. (2004) PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24:1411–1431PubMedCrossRefGoogle Scholar
  18. 18.
    Delbeke D (1999) Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med 40:591–603PubMedGoogle Scholar
  19. 19.
    Engel H, Steinert H, Buck A, et al. (1996) Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. J Nucl Med 37:441–446PubMedGoogle Scholar
  20. 20.
    Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409–1415PubMedCrossRefGoogle Scholar
  21. 21.
    Meyer MA (1995) Diffusely increased colonic F-18 FDG uptake in acute enterocolitis. Clin Nucl Med 20:434–435PubMedCrossRefGoogle Scholar
  22. 22.
    Hannah A, Scott AM, Akhurst T, et al. (1996) Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous Colitis. J Nucl Med 37:1683–1685PubMedGoogle Scholar
  23. 23.
    Bicik I, Bauerfeind P, Breitbach T, von Schulthess GK, Fried M (1997) Inflammatory bowel disease activity measured by positron emission tomography (letter). Lancet 350:262PubMedCrossRefGoogle Scholar
  24. 24.
    Jacobson K, Mernagh JR, Green T, et al. (1999) Positron emission tomography in the investigation of pediatric inflammatory bowel disease. Gastroenterology 116:A742CrossRefGoogle Scholar
  25. 25.
    Kim S, Chung JK, Kim BT, et al. (1999) Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging 2:273–280PubMedCrossRefGoogle Scholar
  26. 26.
    Dong C, Hemminki K (2001) Second primary neoplasms among 53,159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer 85:997–1005PubMedCrossRefGoogle Scholar
  27. 27.
    Even-Sapir E, Lerman H, Gutman M, et al. (2006) The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging 33(5):541–552PubMedCrossRefGoogle Scholar
  28. 28.
    Bonithon-Kopp C, Piard F, Fenger C, et al. (2004) Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 47(3):323–333PubMedCrossRefGoogle Scholar
  29. 29.
    Church JM (2004) Clinical significance of small colorectal polyps. Dis Colon Rectum 47(4):481–485PubMedCrossRefGoogle Scholar
  30. 30.
    Choy AT, van Hasselt CA, Chisholm EM, et al. (1992) Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck. Cancer 70:815–820PubMedCrossRefGoogle Scholar
  31. 31.
    Choi JY, Lee KS, Kwon OJ, et al. (2005) Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 23(30):7654–7659PubMedCrossRefGoogle Scholar
  32. 32.
    Tatlidil R, Jadvar H, Bading JR, Conti PS (2002) Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 224(3):783–787PubMedCrossRefGoogle Scholar
  33. 33.
    Zhuang H, Hickeson M, Chacko TK, et al. (2002) Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med 27(9):628–632PubMedCrossRefGoogle Scholar
  34. 34.
    Agress H Jr, Cooper BZ (2004) Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 230(2):417–422PubMedCrossRefGoogle Scholar
  35. 35.
    Yasuda S, Fujii H, Nakahara T, et al. (2001) 18F-FDG PET detection of colonic adenomas. J Nucl Med 42(7):989–992PubMedGoogle Scholar
  36. 36.
    Chin K, Finger PT, Kurli M, Tena LB, Reddy S (2007) Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma. Optometry 78(8):396–401PubMedGoogle Scholar
  37. 37.
    Hemandas AK, Robson NK, Hickish T, Talbot RW (2008) Colorectal tubulovillous adenomas identified on fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography scans. Colorectal Dis 10(4):386–389PubMedCrossRefGoogle Scholar
  38. 38.
    Cohade C, Osman M, Leal J, et al. (2003) Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44:1797–1803PubMedGoogle Scholar
  39. 39.
    Antoch G, Freudenberg LS, Egelhof T, et al. (2002) Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 43:1339–1342PubMedGoogle Scholar
  40. 40.
    Gutman F, Alberini JL, Wartski M, et al. (2005) Incidental colonic focal lesions detected by FDG PET/CT. AJR Am J Roentgenol 185(2):495–500PubMedGoogle Scholar
  41. 41.
    Kamel EM, Thumshirn M, Truninger K, et al. (2004) Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med 45(11):1804–1810PubMedGoogle Scholar
  42. 42.
    Beatty JS, Williams HT, Aldridge BA, et al. (2009) Incidental PET/CT findings in the cancer patient: how should they be managed? Surgery 146(2):274–281PubMedCrossRefGoogle Scholar
  43. 43.
    van Westreenen HL, Westerterp M, Jager PL, et al. (2005) Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. J Nucl Med 46(8):1321–1325PubMedGoogle Scholar
  44. 44.
    Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46(5):752–757PubMedGoogle Scholar
  45. 45.
    Israel O, Yefremov N, Bar-Shalom R, et al. (2005) PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 46(5):758–762PubMedGoogle Scholar
  46. 46.
    Weston BR, Iyer RB, Qiao W, et al. (2010) Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 116(6):1454–1461PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Diagnostic Imaging ServicesKaiser Permanente Fontana Medical CenterFontanaUSA

Personalised recommendations